In COVID-19 Patients, the Identified Gastrointestinal Symptoms in Tertiary Care Center of India

Murugesan, Malarvizhi; Govindarajan, Ramkumar; Prakash, Lakshmi; Murugan, Chandra Kumar; Jasmine, J Janifer; Krishnasamy, Narayanasamy

doi:10.5005/jp-journals-10018-1371

Euroasian Journal of Hepato-Gastroenterology

2022

DOI: 10.5005/jp-journals-10018-1371

|View full text |Cite

In COVID-19 Patients, the Identified Gastrointestinal Symptoms in Tertiary Care Center of India

Malarvizhi Murugesan¹,

Ramkumar Govindarajan²,

Lakshmi Prakash³

et al.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

Supporting

Mentioning

Contrasting

Year Published

2022

2023

Publication Types

Select...

Article2

Relationship

Self Cite0

Independent2

Authors

Journals

Cited by 2 publications

(1 citation statement)

References 49 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…It is known that SARS-CoV-2 can manifest itself not only in the lungs but also in extra-pulmonary organs, including the intestines, at onset of the disease [ 2 ]. In a recent study from India investigating 956 COVID-19 patients, it was found that gastro-intestinal manifestations precede pulmonary manifestations in the majority of patients [ 3 ]. Thrombocytopenia has also been described as a common manifestation of a SARS-CoV-2 infection, which presumably results from the immune response against the virus, is held responsible for bleeding or thrombosis in COVID-19 patients, and can persist [ 4 ].…”

mentioning

confidence: 99%

Consider SARS-CoV-2 in patients with diarrhoea, vomiting, thrombocytopenia, polyradiculitis, and seizures

Finsterer¹,

Scorza

2022

Annals of Medicine &Amp; Surgery

View full text Add to dashboard Cite

mentioning

confidence: 99%

Consider SARS-CoV-2 in patients with diarrhoea, vomiting, thrombocytopenia, polyradiculitis, and seizures

Finsterer¹,

Scorza

2022

Annals of Medicine &Amp; Surgery

View full text Add to dashboard Cite

Relationship between COVID-19 and Neurological Disorder

Tripathi,

Vishwakarma,

Ojha

et al. 2023

COVID

View full text Add to dashboard Cite

The COVID-19 pandemic has resulted in a socially isolating way of life, and dementia patients are among those who are most affected. Lockdown procedures and the inability to monitor illnesses have led to a rapid decline in cognitive function in these individuals, with neuropsychiatric symptoms, such as agitation, delirium, and impaired motor performance being prevalent. However, the use of antipsychotics in treating these symptoms can increase the risk of death during COVID-19. Effective pain therapy can be used as an alternative to reduce or avoid the use of antipsychotics, given the consistent relationship between agitation and pain in dementia patients. The importance of properly assessing and managing pain in dementia patients is highlighted. Additionally, the article discusses how COVID-19 can affect brain health through inflammation, blood clotting, and blood vessel damage, leading to potential long-term effects on cognitive function. Healthcare professionals must be aware of the increased risk of neuropsychiatric symptoms in dementia patients during the pandemic and prioritize pain management as a viable alternative to antipsychotics. Proper care and attention are necessary to prevent cognitive decline and potential long-term effects on brain health in these vulnerable individuals.

show abstract

scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.

Contact Info

customersupport@researchsolutions.com

10624 S. Eastern Ave., Ste. A-614

Henderson, NV 89052, USA

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Blog Terms and Conditions API Terms Privacy Policy Contact Cookie Preferences Do Not Sell or Share My Personal Information

Made with 💙 for researchers

Part of the Research Solutions Family.

In COVID-19 Patients, the Identified Gastrointestinal Symptoms in Tertiary Care Center of India

Cited by 2 publications

References 49 publications

Consider SARS-CoV-2 in patients with diarrhoea, vomiting, thrombocytopenia, polyradiculitis, and seizures

Consider SARS-CoV-2 in patients with diarrhoea, vomiting, thrombocytopenia, polyradiculitis, and seizures

Relationship between COVID-19 and Neurological Disorder

Contact Info

Product

Resources

About